Thrombin-like enzyme gabonase Antibody
Description
Introduction to Thrombin-Like Enzyme Gabonase Antibody
Gabonase antibodies are designed to neutralize the enzymatic activity of gabonase, a 30.6 kDa glycoprotein with 20.6% carbohydrate content and five disulfide bonds . Unlike human thrombin, gabonase cleaves both fibrinopeptides A and B from fibrinogen, causing substrate inhibition at concentrations above 3 mg/mL . Antibodies targeting this enzyme are critical for studying its pathological effects in envenomation and its potential therapeutic applications.
Key Properties:
| Property | Value/Description |
|---|---|
| Molecular Weight | 30,600 Da (reduced form) |
| Carbohydrate Content | 20.6% |
| Isoelectric Point (pI) | 5.3 |
| Active Site | Serine-histidine catalytic triad |
| Stabilizing Factor | Calcium ions |
Research Findings and Applications
-
Antivenom Development: Gabonase antibodies may mitigate venom-induced coagulopathy by neutralizing fibrinogen depletion and uncontrolled clotting .
-
Coagulation Studies: Gabonase’s factor XIII activation mechanism provides a model for studying thrombus stabilization.
-
Diagnostic Tools: Antibodies could enable ELISA-based detection of gabonase in envenomation cases, leveraging its unique pI (5.3) and carbohydrate markers .
Challenges and Future Directions
Current research gaps include:
-
Epitope Mapping: Precise antibody-binding regions on gabonase remain uncharacterized.
-
Therapeutic Efficacy: In vivo neutralization capacity and cross-reactivity with other snake venom thrombin-like enzymes require validation.
Product Specs
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
